Ravulizumab
Product Specifications
CAS Number
1803171-55-2
Target
Complement System
Related Pathways
Immunology/Inflammation
Purity
>95%
Bioactivity
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation. It can be used for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
029406-AP 100 µL
5-Methylcytosine (5mC, 5-Methyl-Cytosine, 5 MethylCytidine, 5 MeCyd, 5 Me Cytidine) (AP) discontinued
Sign In for Pricing
View Details